Charlotte Ngo is an expert in Oncology at INSERM (France). Charlotte Ngo has authored 114 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 372 (community average: 125). How the SLR is computed.

LeadR Profile

Charlotte Ngo INSERM France
372 ScienceLeadR Reputation 372
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026

Source: PubMed

Centre de Recherche des Cordeliers

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Inventory and needs assessment in francophone LMICs for education, screening and optimal management of breast cancer. The ELISA study.
PMID 41791919 — breast neoplasms, needs assessment, neoplasms, enzyme-linked immunosorbent assay, breast, therapeutics, education
Bull Cancer20260
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.
PMID 41674582 — gastrointestinal stromal tumors, neoplasms, pathology, exons, deep learning, protein-tyrosine kinases, tyrosine, therapeutics, learning, mutation, landslides
medRxiv20260
[Impact of precariousness on breast cancer care in the Île-de-France region: Results of the DESSEIN study].
PMID 38876896 — diagnosis, breast neoplasms, health literacy
Bull Cancer20240
[Time and space in the care pathways of women suffering from breast cancer].
PMID 38879410 — breast neoplasms, neoplasms, breast, therapeutics
Bull Cancer20240
Simultaneous quantification of four hormone therapy drugs by LC-MS/MS: Clinical applications in breast cancer patients.
PMID 38367520 — anastrozole, fulvestrant, estrogens, breast neoplasms, pharmaceutical preparations, chemistry, pharmaceutical, neoplasms, drug monitoring, letrozole, hormones, breast, therapeutics
J Pharm Biomed Anal20244

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 5

By status:

Completed 3
Recruiting 1
Unknown 1

By type:

Interventional 3
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Cancer and Literacy in Health
NCT05008497 — neoplasms, psychometrics, health literacy, literacy
N/ARecruiting2021

LeadR Networks

Main global connection map